CagriGLP/GIP-Tz
Research description
This research set comprises high-purity Cagrilintide (CAS 1415456-99-3) and GLP/GIP-Tz (CAS 2023788-19-2).Engineered for advanced metabolic modeling, this "Tetra-Agonist" combination targets four distinct nutrient-stimulated pathways, GLP-1, GIP, Amylin, and Calcitonin.
Due to distinct pH stability requirements (Acidic for Cagri; Neutral for GLP/GIP-Tz), these reagents are supplied to allow for precise, chemically stable research protocols. Strict USA Cold-Chain maintenance ensures integrity against hydrolytic degradation.
FDA Regulatory Status: FDA Category 2 (Research Use Only).
Not for human consumption, diagnostic, or clinical use.
Unit price
From $153.00
Quantity
Buy more, save more
| Pack | Unit price | Total | Saved |
|---|
- Third-party COA on file Certificate published for every released lot.
- Purity guarantee Independently assay any lot. Below certificate, we refund or replace.
Research use only
For laboratory research use only. Not for human or veterinary use. Not a drug, supplement, food, or cosmetic. Product descriptions summarise published laboratory literature and are not a recommendation for any use in humans or animals.
Every lot released under this product line, newest first. The lot number printed on your vial label resolves to the certificate below — purity, net content, endotoxin, appearance and the number of vials pulled for the conformity panel.
No lots have been published for this product yet.
- CAS number
- Not assigned for this compound
Handling notes
Reconstitution figures for any fill weight and diluent volume can be worked out on the concentration calculator. Solubility and storage data on this page describe laboratory handling of the material only.
This compound is not light-sensitive under normal laboratory lighting. Standard clear containers are acceptable for reconstituted stock.
Sealed storage
- Temperature
- Shelf life
After reconstitution
- Temperature
- Working window
- Light sensitive
- No
In transit
- Note
- Free shipping
- US orders over $200